End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3,570 KRW | +0.28% |
|
-0.42% | -13.14% |
2023 | Tranche Update on Hyundai Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on July 14, 2023. | CI |
2023 | Hyundai Pharmaceutical Co., Ltd.(KOSE:A004310) dropped from S&P Global BMI Index | CI |
Business Summary
Number of employees: 393
Sales per Business
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Medicine
78.3
%
| 130,945 | 80.5 % | 141,510 | 78.3 % | +8.07% |
Food
21.7
%
| 31,745 | 19.5 % | 39,253 | 21.7 % | +23.65% |
Sales per region
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
South Korea
100.0
%
| 162,690 | 100.0 % | 180,763 | 100.0 % | +11.11% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Sang-Joon Lee
CEO | Chief Executive Officer | 47 | 03-02-27 |
Seok-Bong Lee
DFI | Director of Finance/CFO | 67 | 89-05-07 |
Young-Hak Kim
BRD | Director/Board Member | 62 | 07-10-22 |
Ho-Jong Ahn
SAM | Sales & Marketing | 57 | 94-11-30 |
Sang-Hwan Hwang
SAM | Sales & Marketing | 55 | 95-11-30 |
Yi-Soon Hwang
PRN | Corporate Officer/Principal | 62 | 87-07-26 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Han-Gu Lee
CHM | Chairman | 76 | 74-08-08 |
Cheon-Soo Ham
BRD | Director/Board Member | 77 | 99-02-04 |
Sang-Joon Lee
CEO | Chief Executive Officer | 47 | 03-02-27 |
Young-Hak Kim
BRD | Director/Board Member | 62 | 07-10-22 |
Sang-Woo Kim
BRD | Director/Board Member | 50 | 15-02-11 |
Byung-In Lee
BRD | Director/Board Member | 74 | 19-02-10 |
Gun-Seung Lee
BRD | Director/Board Member | 58 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 32,000,000 | 18,568,530 ( 58.03 %) | 5,627,620 ( 17.59 %) | 58.03 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
5,232,471 | 16.35% | 13,775,108 $ | |
WHAN IN PHARM CO.,LTD. 2.62% | 488,000 | 2.62% | 5,103,636 $ |
Company contact information
Hyundai Pharmaceutical Co., Ltd.
55 Jandari-gil Pungse-myeon
31213, Cheonan
+
http://www.hyundaipharm.co.kr![address Hyundai Pharmaceutical Co., Ltd.(A004310)](https://cdn.zonebourse.com/static/address/20699670.png)
Sector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
-13.14% | 71.27M | |
+20.71% | 43.59B | |
+28.00% | 22.54B | |
+21.43% | 15.73B | |
+18.75% | 14.33B | |
+56.13% | 12.75B | |
-0.05% | 6.79B | |
-12.70% | 6.48B | |
-8.87% | 5.73B | |
+15.72% | 5.67B |
- Stock Market
- Equities
- A004310 Stock
- Company Hyundai Pharmaceutical Co., Ltd.